QoL, CIs, QALYs, and Individualized Rehabilitation : The Clinical and Practical Benefits of Regularly Assessing the Quality of Life of Adult Cochlear Implant Recipients
This study aimed to report quality of life (QoL) scores in unilateral cochlear implant (CI) users and to generate guidance for clinicians on using QoL measures to individualize CI counselling and rehabilitation and to increase access to CIs as a mode of rehabilitation. Participants (n = 101) were unilateral CI users with single-sided deafness (SSD; n = 17), asymmetrical hearing loss (AHL; n = 26), or bilateral hearing loss (Uni; n = 58). Generic QoL was assessed via the Health Utilities Index (HUI-3), and disease-specific QoL was assessed via the Speech, Spatial, and Qualities of Hearing scale (SSQ12) and Nijmegen CI Questionnaire (NCIQ) at preimplantation and at 6 and 12 months of CI use. All groups had significantly increased HUI-3 scores at both intervals. The SSD group showed significant benefit on the SSQ12 at visit 3, the AHL group showed significant benefit on the SSQ12 and most NCIQ subdomains at both intervals, and the Uni group showed significant benefit with both tests at both intervals. Unilateral CI recipients demonstrate improved QoL within the first 12 months of device use. Regular assessment with generic and disease-specific questionnaires has the potential to play an important role in personalizing treatment and possibly in increasing access to CI provision.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
International journal of environmental research and public health - 20(2023), 20 vom: 10. Okt. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lassaletta, Luis [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Asymmetrical hearing loss |
|---|
| Anmerkungen: |
Date Completed 30.10.2023 Date Revised 12.11.2023 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.3390/ijerph20206906 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363797130 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363797130 | ||
| 003 | DE-627 | ||
| 005 | 20231226094115.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/ijerph20206906 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1212.xml |
| 035 | |a (DE-627)NLM363797130 | ||
| 035 | |a (NLM)37887644 | ||
| 035 | |a (PII)6906 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lassaletta, Luis |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a QoL, CIs, QALYs, and Individualized Rehabilitation |b The Clinical and Practical Benefits of Regularly Assessing the Quality of Life of Adult Cochlear Implant Recipients |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.10.2023 | ||
| 500 | |a Date Revised 12.11.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a This study aimed to report quality of life (QoL) scores in unilateral cochlear implant (CI) users and to generate guidance for clinicians on using QoL measures to individualize CI counselling and rehabilitation and to increase access to CIs as a mode of rehabilitation. Participants (n = 101) were unilateral CI users with single-sided deafness (SSD; n = 17), asymmetrical hearing loss (AHL; n = 26), or bilateral hearing loss (Uni; n = 58). Generic QoL was assessed via the Health Utilities Index (HUI-3), and disease-specific QoL was assessed via the Speech, Spatial, and Qualities of Hearing scale (SSQ12) and Nijmegen CI Questionnaire (NCIQ) at preimplantation and at 6 and 12 months of CI use. All groups had significantly increased HUI-3 scores at both intervals. The SSD group showed significant benefit on the SSQ12 at visit 3, the AHL group showed significant benefit on the SSQ12 and most NCIQ subdomains at both intervals, and the Uni group showed significant benefit with both tests at both intervals. Unilateral CI recipients demonstrate improved QoL within the first 12 months of device use. Regular assessment with generic and disease-specific questionnaires has the potential to play an important role in personalizing treatment and possibly in increasing access to CI provision | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a asymmetrical hearing loss | |
| 650 | 4 | |a cochlear implant | |
| 650 | 4 | |a patient reported outcome measure | |
| 650 | 4 | |a quality of life | |
| 650 | 4 | |a rehabilitation | |
| 650 | 4 | |a single-side deafness | |
| 700 | 1 | |a Calvino, Miryam |e verfasserin |4 aut | |
| 700 | 1 | |a Sanchez-Cuadrado, Isabel |e verfasserin |4 aut | |
| 700 | 1 | |a Skarzynski, Piotr Henryk |e verfasserin |4 aut | |
| 700 | 1 | |a Cywka, Katarzyna B |e verfasserin |4 aut | |
| 700 | 1 | |a Czajka, Natalia |e verfasserin |4 aut | |
| 700 | 1 | |a Kutyba, Justyna |e verfasserin |4 aut | |
| 700 | 1 | |a Tavora-Vieira, Dayse |e verfasserin |4 aut | |
| 700 | 1 | |a Van de Heyning, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Mertens, Griet |e verfasserin |4 aut | |
| 700 | 1 | |a Staecker, Hinrich |e verfasserin |4 aut | |
| 700 | 1 | |a Humphrey, Bryan |e verfasserin |4 aut | |
| 700 | 1 | |a Zernotti, Mario |e verfasserin |4 aut | |
| 700 | 1 | |a Zernotti, Maximo |e verfasserin |4 aut | |
| 700 | 1 | |a Magele, Astrid |e verfasserin |4 aut | |
| 700 | 1 | |a Ploder, Marlene |e verfasserin |4 aut | |
| 700 | 1 | |a Zabeu, Julia Speranza |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of environmental research and public health |d 2004 |g 20(2023), 20 vom: 10. Okt. |w (DE-627)NLM162777434 |x 1660-4601 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2023 |g number:20 |g day:10 |g month:10 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/ijerph20206906 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2023 |e 20 |b 10 |c 10 | ||